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Sex Med 2Introduction: Erectile dysfunction (ED) can precede coronary artery disease. In addition, silent myocardial
ischemia (SMI) is more common in diabetic patients and is a strong predictor of cardiac events and death.
Aim: To evaluate the presence of SMI in patients with diabetes and ED using multidetector computed
tomographic coronary angiography (MDCT-CA).
Methods: This study evaluated patients with diabetes and ED without any history of cardiac symptoms or signs.
Erectile function was evaluated with the Sexual Health Inventory for Men score, erection hardness score (EHS),
and maximal penile circumferential change by an erectometer. MDCT-CA was used for the detection of
coronary artery stenosis.
Main Outcome Measures: Sexual Health Inventory for Men score, EHS, maximal penile circumferential
change, and coronary artery stenosis by MDCT-CA.
Results: Of 20 patients (mean age ¼ 61.45 ± 10.7 years), MDCT-CA showed coronary artery stenosis in 13
(65%) in the form of one-vessel disease (n ¼ 6, 30%), two-vessel disease (n ¼ 2, 10%), and three-vessel disease
(n ¼ 5, 25%). Fifty percent of patients showed at least 50% vessel lumen obstruction of the left anterior
descending coronary artery, which was the most commonly affected vessel (55%). Fifteen percent (3 of 20) of
patients had greater than 90% stenosis, and two of them underwent an immediate coronary angioplasty with
stenting to prevent myocardial infarction. Maximum coronary artery stenosis was positively correlated with age
(P ¼ 0.016, r ¼ 0.529) and negatively correlated with EHS (P ¼ .046, r ¼ 0.449). Multivariate regression
analysis using age and EHS showed that age was the only independent predictor of SMI (P ¼ .04).
Conclusion:MDCT-CA can be a useful tool to identify SMI in diabetic patients with ED, especially in those of
advanced age and/or with severe ED.
Sex Med 2016;4:e127ee134. Copyright  2016, The Authors. Published by Elsevier Inc. on behalf of the Inter-
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Diabetes mellitus is a major public health problem around the
world. It is estimated that the numbers of adults with diabetes
will increase by 69% in developing countries and by 20% in
developed countries from 2010 through 2030.1 Most patients
with diabetes (90e95%) have type 2 diabetes mellitus.2 The
death rate of diabetic adults is two to four times higher than for
non-diabetic adults,2 with cardiovascular disease (CVD) being
the commonest cause of death.3 The chronic hyperglycemia of
diabetes is associated with macrovascular complications,
including coronary artery disease (CAD), and microvascular
complications that contribute to the pathogenesis of erectilee127
e128 Abdelhamed et aldysfunction (ED).4 A recent systematic review has interpreted
the link between CAD and ED as an interaction of several
factors, including cardiovascular risk factors, androgens, and
chronic inﬂammation, which can lead to endothelial dysfunction
and atherosclerosis, suggesting ED and CAD might be two
different presentations of the same systemic disease.5
The prevalence of ED in diabetic patients varies from 35% to
90%, with risk factors such as age, diabetes duration, glycemic
control, sedentary lifestyle, smoking, and associated comorbid-
ities.6 A meta-analysis has associated ED with increased risk of
CVD events in diabetic patients.7 Even prediabetes identiﬁcation
in patients with ED has been associated with CVD predication.8
Penile color Doppler ultrasound has been recognized as a
potential tool for predicting silent myocardial ischemia (SMI) in
patients with ED.9
Patients with SMI exhibit objective ﬁndings suggestive of
myocardial infarction in the absence of angina or equivalent
symptoms.10 Although the prevalence of SMI is highly variable
depending on the targeted population, age, and diagnostic tools,
diabetes is associated with a marked increase in SMI preva-
lence.11 Several studies have been conducted to screen for SMI in
patients with diabetes using different tools with varying sensi-
tivity and speciﬁcity,12 including electrocardiography,13,14 the
ankle-brachial index,15 nuclear myocardial perfusion imaging
studies,16e18 coronary artery calcium scoring using electron-
beam computed tomography or multidetector computed to-
mography (MDCT),19,20 or a combination of such tests.21
MDCT coronary angiography (MDCT-CA) has become a
reliable non-invasive imaging modality with high speciﬁcity and
sensitivity for the evaluation of CAD.22,23 MDCT-CA has been
used to screen patients with asymptomatic diabetes for SMI,24
providing long-term prognostic value.25 Some studies have
used MDCT-CA to screen for SMI in patients with ED.26e28
However, no previous studies have used MDCT-CA to screen
patients with diabetes and ED.AIM
This prospective study aimed to evaluate the presence of SMI
in diabetic patients with ED using MDCT-CA.METHODS
A prospective clinical study was conducted in diabetic men
with ED seeking treatment at the Men’s Health Clinic at Jun-
tendo University Hospital (Tokyo, Japan) from March 2014
through March 2015. The inclusion criteria for the study were
the absence of current and/or previous cardiac symptoms and
signs. The study design was approved by the ethical and scientiﬁc
research committee of Juntendo University Hospital (number
14-065). The ethical principles of the Declaration of Helsinki
were followed and an informed consent was obtained from all
patients. Diagnosis of diabetes was based on criteria of theAmerican Diabetes Association 2013 guidelines.29 Exclusion
criteria included patients with cerebrovascular disease, congestive
heart failure, congenital or valvular heart disease, cardiomyopa-
thy, arrhythmia, advanced kidney (creatinine > 1.3 mg/dL) or
liver disease, psychiatric disease, history of pelvic trauma, and
pelvic surgery.Initial Evaluation
History taking included a patient’s personal history, special
habits, duration and type of diabetes, associated medical diseases
(hypertension, dyslipidemia), diabetic treatment, and ED
history. History of chronic diabetic complications, including
retinopathy and neuropathy, was obtained. General examination
included weight, height, body mass index, and blood pressure.Laboratory Investigations
Patients’ glycemic control was evaluated by fasting blood
glucose level, glycosylated hemoglobin level, and homeostasis
model assessment of insulin resistance. Hemoglobin, high-
sensitive C-reactive protein, prostate-speciﬁc antigen, and uric
acid were evaluated because they could reﬂect cardiovascular risk
burden. Diabetic nephropathy was evaluated by measuring
albumin, urine b-microglobulins, serum creatinine, and esti-
mated glomerular ﬁltration rate. Patients with albuminuria
(albumin > 30 mg/L) were considered to have nephropathy.
A complete lipid proﬁle, including triglyceride, very low-density
lipoprotein cholesterol, total cholesterol, high-density lipoprotein
cholesterol, low-density lipoprotein cholesterol, ratio of total
cholesterol to high-density lipoprotein cholesterol, apolipopro-
tein A1, and apolipoprotein B, was obtained. Hormonal assess-
ment of total and free testosterone, luteinizing hormone, and
follicle-stimulating hormone levels was performed.Erectile Function Evaluation
Patients’ erectile function was evaluated by three validated
tools. The ﬁrst tool was the Sexual Health Inventory for Men
(SHIM) questionnaire, which evaluated erectile function during
the past 6 months. According to the SHIM score, patients were
categorized as having mild ED (17e21), mild to moderate ED
(12e16), moderate ED (8e11), or severe ED (1e7).30 The
second tool was the erection hardness score (EHS). According to
the EHS, patients were categorized as having optimal erection
(grade ¼ 4), suboptimal erection (grade ¼ 3), moderate ED
(grade ¼ 2), or severe ED (grade ¼ 1).31 The third tool was the
maximal penile circumferential change (MPCC) using an erec-
tometer (Nippon Medical Products, Asahikawa, Japan) during
sleep for three nights. The MPCC measurement has a good
correlation with the RigiScan32 and EHS.33 The ED cutoff point
was an MPCC less than 20 mm, as reported in previous studies.32Evaluation of SMI
A 64-row MDCT scanner (Sensation Cardiac 64; Somatom,
Munich, Germany) was used to evaluate patients. Before MDCTSex Med 2016;4:e127ee134
Table 1. Patients’ clinical and laboratory characteristics (N ¼ 20)*
Parameter
Mean ± SD, median (25the75th percentile),
or percentage Range
History
Age (y) 61.45 ± 10.7 42e81
Smoking 55
Smoking history (y) 37 (14e47) 7e61
Cigarettes/d 20 (12.86e33.33) 1e100
Brinkman smoking index 848.18 ± 453.91 48e1,480
Diabetes duration (y) 6 (4e15) 1e20
ED history (y) 3 (2e7) 1e25
Hypertension 45
Dyslipidemia 30
Retinopathy 0
Neuropathy 5
Diabetes treatment: oral hypoglycemic/insulin 55/45
General examination
Weight (kg) 74.09 ± 17.04 32.6e114
Height (cm) 167.46 ± 5.82 159e179.7
BMI (kg/m2) 26.33 ± 5.94 12.9e41.87
Systolic blood pressure (mmHg) 134 ± 14.17 120e164
Diastolic blood pressure (mmHg) 74.6 ± 7.89 60e88
Laboratory investigations
Fasting blood glucose (mg/dL) 139.5 (121.5e189) 80e413
HbA1c (%) 7.38 ± 1.21 5.8e10.6
HOMA-IR (mU/mL) 15.55 (6.95e37.75) 1e104.8
hsCRP (mg/dL) 0.092 (0.021e0.461) 0.02e1.285
Hb (g/dL) 14.95 ± 1.32 12.8e17.7
PSA (ng/mL) 1.03 (0.47e1.63) 0.2e13.91
Uric acid (mg/dL) 5.94 ± 1.17 3.7e7.3
Albuminuria (mg/L) 20.65 (9.8e51.95) 6.5e1,403
Diabetic nephropathy 35
Urine b2-microglobulins (mg/L) 38 (29e113) 15e322
Creatinine (mg/dL) 0.77 ± 0.2 0.44e1.11
Estimated glomerular ﬁltration rate (mL/min/1.73 m2) 89.26 ± 26.9 49.5e140
Triglyceride (mg/dL) 157.98 ± 91.05 46e424
VLDL cholesterol (mg/dL) 31.58 ± 18.21 9.2e71.6
Total cholesterol (mg/dL) 178 ± 36.88 117e271
HDL cholesterol (mg/dL) 44.24 ± 9.35 27e59
Total cholesterol/HDL ratio 3.7 (3.4e4.9) 2.98e6.69
LDL cholesterol (mg/dL) 104.06 ± 23.68 60e144
Apolipoprotein A1 (mg/dL) 143.8 ± 23.23 111e191
Apolipoprotein B (mg/dL) 92.47 ± 11.96 65e110
Total testosterone (ng/mL) 5.53 ± 2 2.99e10
Free testosterone (pg/mL) 7.75 ± 2.46 4e13.8
LH (mIU/mL) 6.1 (5.1e7.7) 1.8e27.34
FSH (mIU/mL) 8.66 (7.4e11.45) 3.3e50.03
Erectile function evaluation
SHIM score 5 (2.5e8.5) 1e16
EHS 2 (1e2) 1e3
MPCC (mm) 14.5 ± 9.46 2.33e32
BMI ¼ body mass index; ED ¼ erectile dysfunction; EHS ¼ erection hardness score; FSH ¼ follicle-stimulating hormone; Hb ¼ hemoglobin; HbA1c ¼
glycosylated hemoglobin; HDL ¼ high-density lipoprotein; HOMA-IR ¼ homeostasis model assessment of insulin resistance; hsCRP ¼ high sensitive
C-reactive protein; LDL ¼ low-density lipoprotein; LH ¼ luteinizing hormone; MPCC ¼ maximal penile circumferential change; PSA ¼ prostate-speciﬁc
antigen; SHIM ¼ Sexual Health Inventory for Men; VLDL ¼ very low-density lipoprotein.
*Variables with a normal distribution are expressed as mean ± SD. Variables not normally distributed are expressed as median (25the75th percentile).
Categorical variables are expressed as percentage. The Shapiro-Wilk test was used for testing the normality of the variables.
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Table 2. Results of multidetector computed tomographic coronary
angiography (N ¼ 20)*
Parameter Grades n (%)
MDCT-CA result Positive coronary artery
stenosis
13 (65)
MDCT-CA according to
CAD obstruction
Non-obstructive CAD (<50%) 3 (15)
Obstructive CAD (50%) 10 (50)
Quantitative MDCT-CA
stenosis grading
Minimal (<25%) 1 (5)
Mild (25e49%) 2 (10)
Moderate (50e69%) 3 (15)
Severe (70e99%) 7 (35)
Severe (90%) 3 (15)
MDCT-CA according to
number of affected
vessels
1-vessel CAD 6 (30)
2-vessel CAD 2 (10)
3-vessel CAD 5 (25)
MDCT-CA according to
affected vessels
RCA 7 (35)
LMT 2 (10)
LAD 11 (55)
LCX 6 (30)
CAD ¼ coronary artery disease; LAD ¼ left anterior descending coronary
artery; LCX ¼ left circumﬂex coronary artery; LMT ¼ left main trunk
coronary artery; MDCT-CA ¼ multidetector computed tomographic
coronary angiography; RCA ¼ right coronary artery.
*Data are expressed as number of patients (percentage).
Figure 1. Correlation between MDCT maximum coronary artery
stenosis and age using the Pearson correlation test (P ¼ 0.016,
r ¼ 0.529). CAD ¼ coronary artery disease; MDCT ¼multidetector
computed tomography.
e130 Abdelhamed et alscanning, oral metoprolol was administrated to patients to slow
their heart rates to lower than 70 beats/min. After electrocar-
diographic electrodes were connected, patients were asked to
hold their breath during the scan. The scan parameters included
0.5-mm slices thickness, 120-kV tube voltage, and 500-mA tube
current. MDCT-CA results were evaluated as the presence
(positive) or absence (negative) of coronary artery stenosis.
Quantitative grading of maximum coronary artery stenosis as
minimal (<25%), mild (25e49%), moderate (50e69%), and
severe (70e99%) was performed as recommended by the Society
of Cardiovascular Computed Tomography.34 Patients with cor-
onary artery stenosis were classiﬁed according to the decrease in
luminal diameter as having obstructive CAD (50%) or non-
obstructive CAD (<50%).35 The number of stenotic vessels
(one, two, or three) was estimated. Also, coronary artery stenosis
was classiﬁed according to coronary artery nomenclature (right,
left main trunk, left anterior descending, and left circumﬂex
coronary arteries). Patients with positive MDCT-CA results were
informed and followed up (follow-up data incomplete).Statistical Analysis
Correlations between age and maximum stenosis by MDCT-
CA and between EHS and maximum stenosis by MDCT-CA
were performed using the Pearson correlation test with a two-
tailed P value. To identify predictors of SMI, multivariateregression analysis using age and EHS was performed. JMP 11.0
(SAS Institute, Cary, NC, USA) was used for data analysis.
A P value less than .05 was considered signiﬁcant.MAIN OUTCOME MEASURES
The main outcome measurements were the SHIM score, the
EHS, MPCC, and coronary artery stenosis by MDCT-CA.RESULTS
The study included 20 patients with diabetes and ED (mean
age ¼ 61.45 ± 10.7 years). Most patients had type 2 diabetes
(95%) for a median of 6 years (range ¼ 1e20 years). Associated
comorbidities were smoking (55%), hypertension (45%), and
dyslipidemia (30%). All data related to the patients’ character-
istics, including history, general examination, laboratory
investigations, and erectile function, are presented in Table 1.
Erectile function evaluation according to the SHIM score was
5 (range ¼ 1e16); 75% had severe ED (score  7) and 25% had
mild to moderate (score ¼ 12e16) or moderate (score ¼ 8e11)
ED. The patients’ EHS was 2 (range ¼ 1e3), and 78.9% of
patients had an EHS no higher than 2. The MPCC was 11.66
(range ¼ 2.33e32), and 64.3% of patients had an MPCC less
than 20 mm.
MDCT-CA showed positive coronary artery stenosis in 65%
of subjects. Fifty percent of patients showed obstructive CAD
(50% lumen obstruction). One-vessel CAD (30%) was the
commonest presentation. The left anterior descending coronary
artery was the commonest coronary artery with stenosis. Data
related to MDCT-CA are presented in Table 2. Fifteen percent
(3 of 20) of patients had greater than 90% stenosis, and two of
them underwent an immediate coronary angioplasty with
stenting to prevent myocardial infarction. Maximum coronarySex Med 2016;4:e127ee134
Figure 2. Correlation between MDCT maximum coronary artery
stenosis and EHS using the Pearson correlation test (P ¼ 0.046,
r ¼ 0.449). CAD ¼ coronary artery disease; EHS ¼ erection
hardness score; MDCT ¼multidetector computed tomography.
Table 3. Multivariate regression analysis to identify predictors of
silent myocardial ischemia using age and EHS parameters
Variable Sum of square F ratio P value
Age 4,439.132 4.932 .0402
EHS 2,483.168 2.759 .1150
EHS ¼ erection hardness score.
Cardiac Burden in Diabetic Erectile Dysfunction e131artery stenosis was positively correlated with age (P ¼ .016,
r ¼ 0.529; Figure 1) and negatively correlated with EHS
(P ¼ .046, r ¼ 0.449; Figure 2). Multivariate regression
analysis using age and EHS showed that age was the only in-
dependent predictor for SMI (P ¼ .04; Table 3). A representative
MDCT-CA result of one patient is shown in Figure 3.DISCUSSION
The present study examined the magnitude of the effect of ED
on cardiovascular status in diabetic patients using the non-
invasive diagnostic modality of MDCT-CA. The present study
is the ﬁrst to use MDCT-CA in patients with asymptomatic
diabetes and ED; other studies have used MDCT-CA to inves-
tigate patients with only diabetes24,25 or patients with only
ED.26e28 For the relation between ED and CAD, Montorsi
et al35 proposed the artery size hypothesis, which states that when
the penile arteries are smaller (1e2 mm) than the coronary
arteries (3e4 mm), the penile vasculature is affected sooner by
cardiovascular risk factors, which makes ED a predictor of CVD
events. The association between ED and CVD events is well
established,36 especially in diabetic patients.37 Therefore, ED
should be considered an independent CVD risk until proved
otherwise.38
In the present study, MDCT-CA depicted coronary artery
stenosis in 65% of patients with ED and asymptomatic CAD. The
rate of CAD in diabetic patients with concomitant ED is contro-
versial. One study of patients with asymptomatic diabetes screened
with MDCT-CA showed stenosis in 36.5% (19 of 52).24
The present study found that SMI was very common in dia-
betic patients with ED without any cardiac symptoms and signs.
It showed that 50% of patients had signiﬁcant obstructive CAD
(50% decrease in vessel lumen) and 25% of patients had three-
vessel CAD. This is considered an alarming sign becauseSex Med 2016;4:e127ee134obstructive CAD and three-vessel CAD were reported as pre-
dictors of all cardiac events after more than 5 years of follow-up
of 405 diabetic patients.34 In addition, left anterior descending
coronary artery stenosis was reported in 55% of patients, which
was associated with worst prognosis among other myocardial
infarction types owing to a larger infarct, especially with
advanced age.39 Therefore, ED identiﬁcation, especially in
diabetic patients younger than 60 years, could assist in CVD risk
evaluation and decrease the risk of an event.40
A signiﬁcant positive correlation was observed between ED
severity and maximum coronary artery stenosis by MDCT-CA in
diabetic patients. The present results are supported by studies that
used MDCT-CA to screen patients with ED.26,28 In diabetic pa-
tients, increasing ED severity was associated with increased total
CVD risk,41 with poor CVD prognosis.42 Therefore, ED could be
used as a warning sign for SMI. The leading interval from ED to
CVD events was estimated at 2 to 5 years.43 In diabetic patients,
ED is a predictor of CAD and cardiac events, with a 1.4-fold higher
CAD risk compared with diabetic patients without ED.44
Therefore, ED in diabetic patients is considered an atheroscle-
rosis marker that could assist in the detection of subclinical vascular
disorders.45 In patients with diabetes and ED, SMI has been
screened using different stress tests,46e48 showing that the presence
vs absence of ED can improve the sensitivity of screening guide-
lines for SMI in diabetic patients.49
In the present study, age was the only predictor for coronary
artery stenosis in diabetic patients with ED. This result is
consistent with that of a study that showed that increasing age
was an independent risk factor for a high Agatston coronary
artery calcium score in patients with ED.28 In another study, ED
predicted CAD in patients with type 2 diabetes without clinically
evident CVD.50 A prospective study found that predictors of
SMI were diabetes duration, intima-media thickness, and statin
therapy at MDCT-CA screening of patients with asymptomatic
diabetes.24 Recently, MDCT-CA screening of 320 patients with
asymptomatic diabetes showed that a glycosylated hemoglobin
level of at least 7.4%, dyslipidemia, diabetes duration, and reti-
nopathy were predictors for SMI.51 Therefore, MDCT might be
helpful to identify CAD in diabetic patients with ED and high
risk for CVD (including aging) in the future. Radiation exposure
from these screening modalities also should be considered.
The present study has several limitations. The sample was
extracted from outpatients who presented at our clinic seeking for
treatment for ED. Thus, the subjects were from a strongly biased
population. Furthermore, we could not set the controls; therefore,
Figure 3. Representative multidetector computed tomographic coronary angiographic result showing stenosis of the RCA, LAD, and CX in
an 81-year-old man with diabetes and erectile dysfunction. CX ¼ left circumﬂex coronary artery; LAD ¼ left anterior descending coronary
artery; RCA ¼ right coronary artery.
e132 Abdelhamed et alwe could not compare theCADprevalence in diabetic patientswith
EDwith other combinations of disease status, such as subjects with
vs without diabetes and/or with vs without ED. Comparative data
on CAD prevalence in diabetic patients are needed. In addition,
CAD should be assessed separately for type 1 and for type 2 diabetes
owing to different pathogeneses and outcomes. The sample sizewas
limited; therefore, only two parameters (age and ED severity) were
used to assess the predictive factor for SMI. We did this to distin-
guish the stronger predictor for CAD, and we believe this infor-
mation is important for patients with diabetes and ED. The
diagnosis of CAD in diabetic patients with ED was performed
using onlyMDCT-CA, which is an indicator of atherosclerosis but
cannot assess inducible ischemia as stress testing can. Also, coronary
artery calcium scoring was not calculated for the MDCT-CA scan
because we used coronary artery stenosis grading as an outcome
measurement for theMDCT-CA results. In the future, a large-scale
comparative study including healthy men should be performed.CONCLUSIONS
CAD was highly prevalent (65%) in diabetic patients with ED
in our outpatient clinic. Furthermore, 15% of patients showedsevere coronary artery stenosis (90%), which might lead to
myocardial infarction. Age was the single signiﬁcant predictor for
coronary artery stenosis in diabetic patients with ED. One
should consider the possibility of SMI in elderly patients with
diabetes who have ED.Corresponding Author: Shigeo Horie, Department of Urology,
Juntendo University, Hongo 2-1-1, Tokyo, Bunkyo-ku 113-
8421, Japan. Tel: 81-3-3813-3111; Fax: 81-3-5802-1227;
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Conﬂict of Interest: The authors report no conﬂicts of interest.
Funding: None.
STATEMENT OF AUTHORSHIP
Category 1
(a) Conception and Design
Amr Abdelhamed; Shin-ichi Hisasue; Essam A. Nada;
Ali A. Kassem; Mohammed Abdel-Kareem; Shigeo Horie(b) Acquisition of Data
Amr Abdelhamed; Shin-ichi Hisasue; Shigeo HorieSex Med 2016;4:e127ee134
Cardiac Burden in Diabetic Erectile Dysfunction e133(c) Analysis and Interpretation of DataSexAmr Abdelhamed; Shin-ichi Hisasue; Essam A. Nada; Shigeo
HorieCategory 2
(a) Drafting the Article
Amr Abdelhamed; Shin-ichi Hisasue; Essam A. Nada;
Ali A. Kassem; Mohammed Abdel-Kareem; Shigeo Horie(b) Revising It for Intellectual Content
Amr Abdelhamed; Shin-ichi Hisasue; Shigeo HorieCategory 3
(a) Final Approval of the Completed Article
Amr Abdelhamed; Shin-ichi Hisasue; Essam A. Nada;
Ali A. Kassem; Mohammed Abdel-Kareem; Shigeo HorieREFERENCES
1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the
prevalence of diabetes for 2010 and 2030. Diabetes Res Clin
Pract 2010;87:4-14.
2. Centers for Disease Control and Prevention. National
diabetes fact sheet: national estimates and general infor-
mation on diabetes and prediabetes in the United States,
2011. Atlanta, GA: US Department of Health and Human
Services, Centers for Disease Control and Prevention; 2011.
p. 1-12.
3. Roger VL, Go AS, Lloyd-Jones DM, et al; American Heart
Association Statistics Committee and Stroke Statistics Sub-
committee. Heart disease and stroke statistics—2012 update:
a report from the American Heart Association. Circulation
2012;125:e2-e220.
4. Fowler MJ. Microvascular and macrovascular complications of
diabetes. Clin Diabetes 2008;26:77-82.
5. Gandaglia G, Briganti A, Jackson G, et al. A systematic review
of the association between erectile dysfunction and cardio-
vascular disease. Eur Urol 2014;65:968-978.
6. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus.
J Sex Med 2009;6:1232-1247.
7. Yamada T, Hara K, Umematsu H, et al. Erectile dysfunction
and cardiovascular events in diabetic men: a meta-analysis of
observational studies. PLoS One 2012;7:e43673.
8. Corona G, Rastrelli G, Silverii A, et al. The identiﬁcation of
prediabetes condition with ARIC algorithm predicts long-term
CV events in patients with erectile dysfunction. J Sex Med
2013;10:1114-1123.
9. Corona G, Fagioli G, Mannucci E, et al. Penile Doppler ultra-
sound in patients with erectile dysfunction (ED): role of peak
systolic velocity measured in the ﬂaccid state in predicting
arteriogenic ED and silent coronary artery disease. J Sex Med
2008;5:2623-2634.
10. Tabibiazar R, Edelman SV. Silent ischemia in people with dia-
betes: a condition that must be heard. Clin Diabetes 2003;
21:5-9.
11. Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive
factors and prognosis of silent myocardial infarction: a review
of the literature. Arch Cardiovasc Dis 2011;104:178-188.Med 2016;4:e127ee13412. Fox CS, Golden SH, Anderson C, et al; American Heart Asso-
ciation Diabetes Committee of the Council on Lifestyle and
Cardiometabolic Health, Council on Clinical Cardiology, Council
on Cardiovascular and Stroke Nursing, Council on Cardiovas-
cular Surgery and Anesthesia, Council on Quality of Care and
Outcomes Research, American Diabetes Association. Update
on prevention of cardiovascular disease in adults with type 2
diabetes mellitus in light of recent evidence: a scientiﬁc state-
ment from the American Heart Association and the American
Diabetes Association. Diabetes Care 2015;38:1777-1803.
13. Davis TM, Coleman RL, Holman RR. Prognostic signiﬁcance of
silent myocardial infarction in newly diagnosed type 2 diabetes
mellitus: United Kingdom Prospective Diabetes Study
(UKPDS) 79. Circulation 2013;127:980-987.
14. Scheidt-Nave C, Barrett-Connor E, Wingard DL. Resting elec-
trocardiographic abnormalities suggestive of asymptomatic
ischemic heart disease associated with noneinsulin-dependent
diabetes mellitus in a deﬁned population. Circulation 1990;
81:899-906.
15. Doobay AV, Anand SS. Sensitivity and speciﬁcity of the ankle-
brachial index to predict future cardiovascular outcomes:
a systematic review. Arterioscler Thromb Vasc Biol 2005;
25:1463-1469.
16. Prevalence of unrecognized silent myocardial ischemia and its
association with atherosclerotic risk factors in noninsulin-
dependent diabetes mellitus. Milan Study on Atherosclerosis
and Diabetes (MiSAD) Group. Am J Cardiol 1997;79:134-139.
17. Young LH, Wackers FJ, Chyun DA, et al; DIAD Investigators.
Cardiac outcomes after screening for asymptomatic coronary
artery disease in patients with type 2 diabetes: the DIAD study:
a randomized controlled trial. JAMA 2009;301:1547-1555.
18. Lièvre MM, Moulin P,Thivolet C, et al; DYNAMIT investigators.
Detection of silent myocardial ischemia in asymptomatic pa-
tients with diabetes: results of a randomized trial and meta-
analysis assessing the effectiveness of systematic screening.
Trials 2011;12:23.
19. Elkeles RS, Godsland IF, Feher MD, et al; PREDICT Study Group.
Coronary calcium measurement improves prediction of car-
diovascular events in asymptomatic patients with type 2 dia-
betes: the PREDICTstudy. Eur Heart J 2008;29:2244-2251.
20. Scholte AJ, Schuijf JD, Kharagjitsingh AV, et al. Prevalence of
coronary artery disease and plaque morphology assessed by
multi-slice computed tomography coronary angiography and
calcium scoring in asymptomatic patients with type 2 dia-
betes. Heart 2008;94:290-295.
21. Scholte AJ, Bax JJ, Wackers FJ. Screening of asymptomatic
patients with type 2 diabetes mellitus for silent coronary artery
disease: combined use of stress myocardial perfusion imaging
and coronary calcium scoring. J Nucl Cardiol 2006;13:11-18.
22. Khan A, Khosa F, Nasir K, et al. Comparison of radiation dose
and image quality: 320-MDCT versus 64-MDCT coronary
angiography. AJR Am J Roentgenol 2011;197:163-168.
23. Meijer AB, O YL, Geleijns J, et al. Meta-analysis of 40- and
64-MDCTangiography for assessing coronary artery stenosis.
AJR Am J Roentgenol 2008;191:1667-1675.
24. Nishioka H, Furukawa N, Shimoda S, et al. Predictors of cor-
onary heart disease in Japanese patients with type 2 diabetes:
e134 Abdelhamed et alscreening for coronary artery stenosis using multidetector
computed tomography. J Diabetes Invest 2010;1:50-55.
25. Andreini D, Pontone G, Mushtaq S, et al. Prognostic value of
multidetector computed tomography coronary angiography in
diabetes: excellent long-term prognosis in patients with
normal coronary arteries. Diabetes Care 2013;36:1834-1841.
26. Yaman O, Gulpinar O, Hasan T, et al. Erectile dysfunction may
predict coronary artery disease: relationship between coronary
artery calcium scoring and erectile dysfunction severity. Int
Urol Nephrol 2008;40:117-123.
27. Jackson G. Erectile dysfunction and asymptomatic coronary
artery disease: frequently detected by computed tomography
coronary angiography but not by exercise electrocardiography.
Int J Clin Pract 2013;67:1159-1162.
28. Umul M, Semerci B, Umul A, et al. Relationship between
erectile dysfunction and silent coronary artery disease:
detection with multidetector computed tomography coronary
angiography. Urol Int 2014;92:310-315.
29. Standards of medical care in diabetes—2013. Diabetes Care
2013;36(Suppl. 1):S11-S66.
30. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men
(SHIM): a 5-year review of research and clinical experience.
Int J Impot Res 2005;17:307-319.
31. Mulhall JP, Goldstein I, Bushmakin AG, et al. Validation of the
erection hardness score. J Sex Med 2007;4:1626-1634.
32. Suzuki K, Sato Y, Horita H, et al. The correlation between
penile tumescence measured by the erectometer and penile
rigidity by the RigiScan. Int J Urol 2001;8:594-598.
33. Matsuda Y, Hisasue S, Kumamoto Y, et al. Correlation be-
tween erection hardness score and nocturnal penile tumes-
cence measurement. J Sex Med 2014;11:2272-2276.
34. Raff GL, Abidov A, Achenbach S, et al; Society of Cardiovas-
cular Computed Tomography. SCCT guidelines for the
interpretation and reporting of coronary computed tomo-
graphic angiography. J Cardiovasc Comput Tomogr 2009;
3:122-136.
35. Montorsi P, Ravagnani PM, Galli S, et al. The artery size hy-
pothesis: amacrovascular link between erectile dysfunction and
coronary artery disease. Am J Cardiol 2005;96:19m-23m.
36. Guo W, Liao C, Zou Y, et al. Erectile dysfunction and risk of
clinical cardiovascular events: a meta-analysis of seven cohort
studies. J Sex Med 2010;7:2805-2816.
37. Batty GD, Li Q, Czernichow S, et al; ADVANCE Collaborative
Group. Erectile dysfunction and later cardiovascular disease in
men with type 2 diabetes: prospective cohort study based on
the ADVANCE (Action in Diabetes and Vascular Disease:
Preterax and Diamicron Modiﬁed-Release Controlled Evalua-
tion) trial. J Am Coll Cardiol 2010;56:1908-1913.
38. Montorsi P, Ravagnani PM, Galli S, et al. Association between
erectile dysfunction and coronary artery disease: matching theright target with the right test in the right patient. Eur Urol
2006;50:721-731.
39. Kyto V, Sipila J, Rautava P. Association of age and gender with
anterior location of STEMI. Int J Cardiol 2014;176:1161-1162.
40. Miner M, Seftel AD, Nehra A, et al. Prognostic utility of erectile
dysfunction for cardiovascular disease in younger men and
those with diabetes. Am Heart J 2012;164:21-28.
41. Meena BL, Kochar DK, Agarwal TD, et al. Association between
erectile dysfunction and cardiovascular risk in individuals with
type-2 diabetes without overt cardiovascular disease. Int
J Diabetes Dev Ctries 2009;29:150-154.
42. Heruti RJ, Uri I, Arbel Y, et al. Erectile dysfunction severity
might be associated with poor cardiovascular prognosis in
diabetic men. J Sex Med 2007;4:465-471.
43. Jackson G, Boon N, Eardley I, et al. Erectile dysfunction and
coronary artery disease prediction: evidence-based guidance
and consensus. Int J Clin Pract 2010;64:848-857.
44. Gandaglia G, Salonia A, Passoni N, et al. Erectile dysfunction
as a cardiovascular risk factor in patients with diabetes.
Endocrine 2013;43:285-292.
45. González-Juanatey JR, Alegría Ezquerra E, Gomis Barberá R,
et al; Estudio DIVA. [Erectile dysfunction as a marker of silent
cardiovascular disease in type-2 diabetic patients in Spain. The
DIVA (DIabetes and VAscular disease) study]. Med Clin 2009;
132:291-297 [in Spanish].
46. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship
between erectile dysfunction and silent myocardial ischemia in
apparently uncomplicated type 2 diabetic patients. Circulation
2004;110:22-26.
47. Gazzaruso C, Solerte SB, Pujia A, et al. Erectile dysfunction as
a predictor of cardiovascular events and death in diabetic
patients with angiographically proven asymptomatic coronary
artery disease: a potential protective role for statins and
5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008;
51:2040-2044.
48. García-Malpartida K, Mármol R, Jover A, et al. Relationship
between erectile dysfunction and silent myocardial ischemia in
type 2 diabetic patients with no known macrovascular com-
plications. J Sex Med 2011;8:2606-2616.
49. Gazzaruso C, Coppola A, Montalcini T, et al. Erectile dysfunc-
tion can improve the effectiveness of the current guidelines for
the screening for asymptomatic coronary artery disease in
diabetes. Endocrine 2011;40:273-279.
50. Ma RC, So WY, Yang X, et al. Erectile dysfunction predicts
coronary heart disease in type 2 diabetes. J Am Coll Cardiol
2008;51:2045-2050.
51. Shimabukuro M, Saito T, Higa T, et al. Risk stratiﬁcation of
coronary artery disease in asymptomatic diabetic subjects
using multidetector computed tomography. Circ J 2015;
79:2422-2429.Sex Med 2016;4:e127ee134
